{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:07:50Z","timestamp":1764079670181,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12325-021-01799-3","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:02:49Z","timestamp":1623409369000},"page":"4013-4025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Number of Pills, Rather Than the Type of Renin\u2013Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-0181","authenticated-orcid":false,"given":"Riccardo","family":"Sarzani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Filipponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Marziali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Ristori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Garbuglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Biondini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Allevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Spannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"issue":"9438","key":"1799_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"PS Yusuf","year":"2004","unstructured":"Yusuf PS, Hawken S, \u00d4unpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"6","key":"1799_CR2","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s12325-019-00941-6","volume":"36","author":"F Spannella","year":"2019","unstructured":"Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded \u201cdouble-trouble\u201d lipid profile in overweight\/obese. Adv Ther. 2019;36(6):1426\u201337.","journal-title":"Adv Ther"},{"issue":"2","key":"1799_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40292-014-0054-3","volume":"21","author":"R Sarzani","year":"2014","unstructured":"Sarzani R, Bordicchia M, Spannella F, Dess\u00ec-Fulgheri P, Fedecostante M. Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors. High Blood Press Cardiovasc Prev. 2014;21(2):81\u20137.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"12","key":"1799_CR4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension ESC\/ESH task force for the management of arterial hypertension. J Hypertens. 2018;36(12):2284\u2013309.","journal-title":"J Hypertens"},{"issue":"7","key":"1799_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","volume":"2","author":"JD Bundy","year":"2017","unstructured":"Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality a systematic review and network meta-analysis. JAMA Cardiol. 2017;2(7):775\u201381.","journal-title":"JAMA Cardiol"},{"issue":"10022","key":"1799_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367.","journal-title":"Lancet"},{"issue":"12","key":"1799_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","volume":"324","author":"P Muntner","year":"2020","unstructured":"Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999\u20132000 to 2017\u20132018. JAMA. 2020;324(12):1190\u2013200.","journal-title":"JAMA"},{"issue":"5","key":"1799_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1742-1241.2009.01999.x","volume":"63","author":"M Burnier","year":"2009","unstructured":"Burnier M, Brown RE, Ong SH, Keskinaslan A, Khan ZM. Issues in blood pressure control and the potential role of single-pill combination therapies. Int J Clin Pract. 2009;63(5):790\u20138.","journal-title":"Int J Clin Pract"},{"issue":"17","key":"1799_CR9","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s40265-019-01209-7","volume":"79","author":"M Leggio","year":"2019","unstructured":"Leggio M, Fusco A, Loreti C, et al. Fixed and low-dose combinations of blood pressure-lowering agents: for the many or the few? Drugs. 2019;79(17):1831\u20137.","journal-title":"Drugs"},{"issue":"3","key":"1799_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290\u2013300.","journal-title":"Am J Med"},{"issue":"11","key":"1799_CR11","doi-asserted-by":"publisher","first-page":"e006986","DOI":"10.1161\/JAHA.117.006986","volume":"6","author":"TM MacDonald","year":"2017","unstructured":"MacDonald TM, Williams B, Webb DJ, et al. Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial. J Am Heart Assoc. 2017;6(11):e006986.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1799_CR12","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1097\/HJH.0000000000002598","volume":"38","author":"E Campana","year":"2020","unstructured":"Campana E, Cunha V, Glaveckaite S, et al. The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice. J Hypertens. 2020;38(12):2369\u201377.","journal-title":"J Hypertens"},{"issue":"3","key":"1799_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41371-018-0138-y","volume":"33","author":"C Dimou","year":"2019","unstructured":"Dimou C, Antza C, Akrivos E, et al. A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension. J Hum Hypertens. 2019;33(3):188\u2013201.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"1799_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","volume":"91","author":"S Bangalore","year":"2016","unstructured":"Bangalore S, Fakheri R, Toklu B, Ogedegbe G, Weintraub H, Messerli FH. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials. Mayo Clin Proc. 2016;91(1):51\u201360.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1799_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40292-020-00396-9","volume":"27","author":"F Giulietti","year":"2020","unstructured":"Giulietti F, Filipponi A, Rosettani G, et al. Pharmacological approach to smoking cessation: an updated review for daily clinical practice. High Blood Press Cardiovasc Prev. 2020;27(5):349\u201362.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"5","key":"1799_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/jch.12963","volume":"19","author":"F Spannella","year":"2017","unstructured":"Spannella F, Giulietti F, Fedecostante M, et al. Interarm blood pressure differences predict target organ damage in type 2 diabetes. J Clin Hypertens. 2017;19(5):472\u20138.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"1799_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MBP.0000000000000135","volume":"20","author":"S Omboni","year":"2015","unstructured":"Omboni S, Palatini P, Parati G. Standards for ambulatory blood pressure monitoring clinical reporting in daily practice: recommendations from the Italian Society of Hypertension. Blood Press Monit. 2015;20(5):241\u20134.","journal-title":"Blood Press Monit"},{"issue":"8","key":"1799_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/HJH.0000000000002089","volume":"37","author":"A Salam","year":"2019","unstructured":"Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A. Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37(8):1567\u201373.","journal-title":"J Hypertens"},{"issue":"7404","key":"1799_CR19","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Br Med J. 2003;326(7404):1427.","journal-title":"Br Med J"},{"issue":"3","key":"1799_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/HJH.0000000000002276","volume":"38","author":"F Spannella","year":"2020","unstructured":"Spannella F, Filipponi A, Giulietti F, Di Pentima C, Bordoni V, Sarzani R. Statin therapy is associated with better ambulatory blood pressure control: a propensity score analysis. J Hypertens. 2020;38(3):546\u201352.","journal-title":"J Hypertens"},{"issue":"2","key":"1799_CR21","doi-asserted-by":"publisher","first-page":"L325","DOI":"10.1152\/ajplung.00189.2020","volume":"319","author":"R Sarzani","year":"2020","unstructured":"Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Am J Physiol Lung Cell Mol Physiol. 2020;319(2):L325\u201336.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"Suppl1","key":"1799_CR22","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1038\/sj.jhh.1000991","volume":"14","author":"ZH Israili","year":"2000","unstructured":"Israili ZH. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens. 2000;14(Suppl1):S73-86.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"1799_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.mce.2008.06.006","volume":"302","author":"I Van Liefde","year":"2009","unstructured":"Van Liefde I, Vauquelin G. Sartan-AT1 receptor interactions: In vitro evidence for insurmountable antagonism and inverse agonism. Mol Cell Endocrinol. 2009;302(2):237\u201343.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"1799_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/jhh.2013.6","volume":"27","author":"G B\u00f6nner","year":"2013","unstructured":"B\u00f6nner G, Bakris GL, Sica D, et al. Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril. J Hum Hypertens. 2013;27(8):479\u201386.","journal-title":"J Hum Hypertens"},{"issue":"7","key":"1799_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1097\/HJH.0b013e32835466ac","volume":"30","author":"S Omboni","year":"2012","unstructured":"Omboni S, Malacco E, Mallion JM, Volpe M, Zanchetti A. Twenty-four hour and early morning blood pressure control of olmesartan vs ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies. J Hypertens. 2012;30(7):1468\u201377.","journal-title":"J Hypertens"},{"issue":"5","key":"1799_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jacc.2010.07.053","volume":"57","author":"FH Messerli","year":"2011","unstructured":"Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol. 2011;57(5):590\u2013600.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1799_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","volume":"115","author":"AU Klingbeil","year":"2003","unstructured":"Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115(1):41\u20136.","journal-title":"Am J Med"},{"issue":"39","key":"1799_CR28","doi-asserted-by":"publisher","first-page":"e1560","DOI":"10.1097\/MD.0000000000001560","volume":"94","author":"R Xu","year":"2015","unstructured":"Xu R, Sun S, Huo Y, et al. Effects of ACEIs versus ARBs on proteinuria or albuminuria in primary hypertension: a meta-analysis of randomized trials. Medicine (Baltimore). 2015;94(39):e1560.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1799_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10557-018-6841-7","volume":"33","author":"YH Kim","year":"2019","unstructured":"Kim YH, Her AY, Jeong MH, et al. Comparison between beta-blockers with angiotensin-converting enzyme inhibitors and beta-blockers with angiotensin II type I receptor blockers in ST-segment elevation myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents. Cardiovasc Drugs Ther. 2019;33(1):55\u201367.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1799_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2019.08.018","volume":"289","author":"YH Kim","year":"2019","unstructured":"Kim YH, Her AY, Jeong MH, et al. A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents. Atherosclerosis. 2019;289:109\u201317.","journal-title":"Atherosclerosis"},{"key":"1799_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2019.11.086","volume":"306","author":"SH Ann","year":"2020","unstructured":"Ann SH, Strauss MH, Park G-M, et al. Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention. Int J Cardiol Neth. 2020;306:35\u201341.","journal-title":"Int J Cardiol Neth"},{"key":"1799_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pcad.2015.11.004","volume":"58","author":"MH Strauss","year":"2016","unstructured":"Strauss MH, Hall AS. The divergent cardiovascular effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on myocardial infarction and death. Prog Cardiovasc Dis US. 2016;58:473\u201382.","journal-title":"Prog Cardiovasc Dis US"},{"key":"1799_CR33","doi-asserted-by":"publisher","first-page":"e1921618","DOI":"10.1001\/jamanetworkopen.2019.21618","volume":"3","author":"J Wei","year":"2020","unstructured":"Wei J, Galaviz KI, Kowalski AJ, et al. Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis. JAMA Netw Open. 2020;3:e1921618.","journal-title":"JAMA Netw Open"},{"issue":"13","key":"1799_CR34","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","volume":"71","author":"FH Messerli","year":"2018","unstructured":"Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol. 2018;71(13):1474\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1799_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/jch.13272","volume":"20","author":"LP Du","year":"2018","unstructured":"Du LP, Cheng ZW, Zhang YX, Li Y, Mei D. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. J Clin Hypertens. 2018;20(5):902\u20137.","journal-title":"J Clin Hypertens"},{"issue":"2","key":"1799_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55(2):399\u2013407.","journal-title":"Hypertension"},{"issue":"6","key":"1799_CR37","doi-asserted-by":"publisher","first-page":"e1002584","DOI":"10.1371\/journal.pmed.1002584","volume":"15","author":"AA Verma","year":"2018","unstructured":"Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study. PLoS Med. 2018;15(6):e1002584.","journal-title":"PLoS Med"},{"issue":"1 Suppl 1","key":"1799_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1524-6175.2007.08028.x","volume":"10","author":"WJ Elliott","year":"2008","unstructured":"Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich). 2008;10(1 Suppl 1):20\u20136.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3_suppl","key":"1799_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/2047487317709116","volume":"24","author":"MEAM van Kleef","year":"2017","unstructured":"van Kleef MEAM, Spiering W. Hypertension: overly important but under-controlled. Eur J Prev Cardiol. 2017;24(3_suppl):36\u201343.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"1799_CR40","doi-asserted-by":"publisher","first-page":"e5641","DOI":"10.1097\/MD.0000000000005641","volume":"96","author":"TM Abegaz","year":"2017","unstructured":"Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4):e5641.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1799_CR41","doi-asserted-by":"publisher","first-page":"e0161285","DOI":"10.1371\/journal.pone.0161285","volume":"11","author":"SG Mallat","year":"2016","unstructured":"Mallat SG, Tanios BY, Itani HS, Lotfi T, Akl EA. Free versus fixed combination antihypertensive therapy for essential arterial hypertension: a systematic review and meta-analysis. PLoS ONE. 2016;11(8):e0161285.","journal-title":"PLoS ONE"},{"issue":"4","key":"1799_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/jch.13240","volume":"20","author":"P Bramlage","year":"2018","unstructured":"Bramlage P, Schmidt S, Sims H. Fixed-dose vs free-dose combinations for the management of hypertension\u2014an analysis of 81 958 patients. J Clin Hypertens. 2018;20(4):705\u201315.","journal-title":"J Clin Hypertens"},{"issue":"1","key":"1799_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40119-017-0085-7","volume":"6","author":"SV Nedogoda","year":"2017","unstructured":"Nedogoda SV, Stojanov VJ. Single-pill combination of perindopril\/indapamide\/amlodipine in patients with uncontrolled hypertension: a randomized controlled trial. Cardiol Ther. 2017;6(1):91\u2013104.","journal-title":"Cardiol Ther"},{"issue":"6","key":"1799_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jama.2018.10359","volume":"320","author":"R Webster","year":"2018","unstructured":"Webster R, Salam A, De Silva HA, et al. Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka a randomized clinical trial. JAMA. 2018;320(6):566\u201379.","journal-title":"JAMA"},{"issue":"6","key":"1799_CR45","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/HJH.0000000000002381","volume":"38","author":"K Tsioufis","year":"2020","unstructured":"Tsioufis K, Kreutz R, Sykara G, van Vugt J, Hassan T. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. J Hypertens. 2020;38(6):1016\u201328.","journal-title":"J Hypertens"},{"issue":"7","key":"1799_CR46","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/HJH.0000000000001359","volume":"35","author":"JJ Mourad","year":"2017","unstructured":"Mourad JJ, Amodeo C, De Champvallins M, Brzozowska-Villatte R, Asmar R. Blood pressure-lowering efficacy and safety of perindopril\/indapamide\/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial. J Hypertens. 2017;35(7):1481\u201395.","journal-title":"J Hypertens"},{"issue":"3","key":"1799_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12325-018-0675-3","volume":"35","author":"SV Fleig","year":"2018","unstructured":"Fleig SV, Weger B, Haller H, Limbourg FP. Effectiveness of a fixed-dose, single-pill combination of perindopril and amlodipine in patients with hypertension: a non-interventional study. Adv Ther. 2018;35(3):353\u201366.","journal-title":"Adv Ther"},{"issue":"2","key":"1799_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/HJH.0000000000000409","volume":"33","author":"G Mancia","year":"2015","unstructured":"Mancia G, Asmar R, Amodeo C, et al. Comparison of single-pill strategies first line in hypertension: perindopril\/amlodipine versus valsartan\/amlodipine. J Hypertens. 2015;33(2):401\u201311.","journal-title":"J Hypertens"},{"key":"1799_CR49","doi-asserted-by":"publisher","first-page":"109539","DOI":"10.1016\/j.biopha.2019.109539","volume":"120","author":"A Mazza","year":"2019","unstructured":"Mazza A, Townsend DM, Schiavon L, et al. Long-term effect of the perindopril\/indapamide\/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects. Biomed Pharmacother. 2019;120:109539.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1799_CR50","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s12325-017-0511-1","volume":"34","author":"A Mazza","year":"2017","unstructured":"Mazza A, Lenti S, Schiavon L, et al. Fixed-dose triple combination of antihypertensive drugs improves blood pressure control: from clinical trials to clinical practice. Adv Ther. 2017;34(4):975\u201385.","journal-title":"Adv Ther"},{"issue":"9","key":"1799_CR51","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/jch.13344","volume":"20","author":"P Balietti","year":"2018","unstructured":"Balietti P, Spannella F, Giulietti F, et al. Ten-year changes in ambulatory blood pressure: the prognostic value of ambulatory pulse pressure. J Clin Hypertens. 2018;20(9):1230\u20137.","journal-title":"J Clin Hypertens"},{"issue":"10","key":"1799_CR52","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41371-018-0140-4","volume":"33","author":"F Spannella","year":"2019","unstructured":"Spannella F, Filipponi A, Giulietti F, et al. Prognostic role of masked and white-coat hypertension: 10-year mortality in treated elderly hypertensives. J Hum Hypertens. 2019;33(10):741\u20137.","journal-title":"J Hum Hypertens"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01799-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T21:30:39Z","timestamp":1634592639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01799-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1799"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01799-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"10 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version was revised due to update in funding note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}